Acrivon Therapeutics Inc. Common Stock (ACRV) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Acrivon Therapeutics Inc....

NASDAQ: ACRV · Real-Time Price · USD
1.91
0.05 (2.69%)
At close: Oct 03, 2025, 3:59 PM
1.91
-0.04%
After-hours: Oct 03, 2025, 06:51 PM EDT

Acrivon Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-80.56M -60.39M -31.17M -16.24M
Depreciation & Amortization
1.01M 536K 364K 37K
Stock-Based Compensation
14.29M 11.62M 2.19M 497K
Other Working Capital
6.02M 4.53M -1.29M -470K
Other Non-Cash Items
-2.85M 1.06M 33K 1.14M
Deferred Income Tax
n/a -3.61M n/a 255K
Change in Working Capital
2.44M 8.14M -1.53M 328K
Operating Cash Flow
-65.67M -42.64M -30.12M -13.98M
Capital Expenditures
-2.77M -1.29M -2.17M -238K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-202.93M -56.53M -150.18M n/a
Sales Maturities Of Investments
153.92M 108.53M 10.67M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-51.77M 50.72M -141.68M -238K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51.03M -1.3M -2.75M 1K
Financial Cash Flow
121.03M -1.55M 101.71M 112.22M
Net Cash Flow
3.59M 6.52M -70.08M 98M
Free Cash Flow
-68.44M -43.93M -32.28M -14.22M